US Edition
News from HealthTech HotSpot
Information about HealthTech HotSpot
Where is HealthTech HotSpot located?HealthTech HotSpot's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top HealthTech HotSpot News
Stoughton, Wisconsin · StoughtonAbbVie and Genmab’s cancer drug Epkinly failed to improve overall survival in a late-stage study for diffuse large B cell lymphoma.
The Phase 3 trial enrolled patients who had received at least one prior therapy ...See the Story
DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
80% Center coverage: 10 sources
FDA · United StatesImmunityBio plans to resubmit its Anktiva FDA application after new feedback, sharing long-term data that shows high survival and bladder preservation in certain bladder cancer patients.See the Story
Why Is ImmunityBio Stock Trading Higher Today - ImmunityBio (NASDAQ:IBRX)
60% Center coverage: 5 sources
